Literature DB >> 20647044

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.

Eline Thomson1, Siobhain Brennan, Revathy Senthilmohan, Catherine L Gangell, Anna L Chapman, Peter D Sly, Anthony J Kettle, Elizabeth Balding, Luke J Berry, John B Carlin, Rosemary Carzino, Nick de Klerk, Tonia Douglas, Clara Foo, Luke W Garratt, Graham L Hall, Jo Harrison, Anthony Kicic, Ingrid A Laing, Karla M Logie, John Massie, Lauren S Mott, Conor Murray, Faith Parsons, Naveen Pillarisetti, Srinivas R Poreddy, Sarath C Ranganathan, Colin F Robertson, Roy Robins-Browne, Philip J Robinson, Billy Skoric, Stephen M Stick, Erika N Sutanto, Elizabeth Williamson.   

Abstract

We aimed to determine whether myeloperoxidase (MPO) is the main peroxidase present in the airways of children with cystic fibrosis (CF) and to assess which oxidants it produces and whether they are associated with clinical features of CF. Children with CF (n=54) and without CF (n=16) underwent bronchoscopy and bronchoalveolar lavage (BAL) for assessment of pulmonary infection and inflammation. BAL fluid was analyzed for MPO, halogenated tyrosines as markers of hypohalous acids, thiocyanate, and protein carbonyls. MPO was the only peroxidase detected in BAL samples from children with CF and its concentration was markedly higher than in controls. Levels of 3-chlorotyrosine and 3-bromotyrosine in proteins were higher in the CF group. They correlated with neutrophils and MPO. The concentration of thiocyanate in BAL samples was below 1μM. Protein carbonyl levels correlated with MPO and halogenated tyrosines in patients with CF. Levels of MPO and halogenated tyrosines were higher in children with infections, especially Pseudomonas aeruginosa, and in the presence of respiratory symptoms. They also correlated with the Kanga clinical score. Our findings suggest that MPO produces hypobromous acid as well as hypochlorous acid in the airways of children with CF and that these oxidants are involved in the early pathogenesis of CF.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647044     DOI: 10.1016/j.freeradbiomed.2010.07.010

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  34 in total

Review 1.  Redox balance in cystic fibrosis.

Authors:  Assem G Ziady; Jason Hansen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-20       Impact factor: 5.085

Review 2.  Oxidation as an important factor of protein damage: Implications for Maillard reaction.

Authors:  L Trnkova; J Drsata; I Bousova
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

3.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.

Authors:  Aaron Roth; Sean Ott; Kelli M Farber; Teresa A Palazzo; Wayne E Conrad; Makhluf J Haddadin; Dean J Tantillo; Carroll E Cross; Jason P Eiserich; Mark J Kurth
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

Review 4.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

5.  Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.

Authors:  Joshua D Chandler; Camilla Margaroli; Hamed Horati; Matthew B Kilgore; Mieke Veltman; H Ken Liu; Alexander J Taurone; Limin Peng; Lokesh Guglani; Karan Uppal; Young-Mi Go; Harm A W M Tiddens; Bob J Scholte; Rabindra Tirouvanziam; Dean P Jones; Hettie M Janssens
Journal:  Eur Respir J       Date:  2018-10-10       Impact factor: 16.671

Review 6.  Biomarkers for cystic fibrosis drug development.

Authors:  Marianne S Muhlebach; J P Clancy; Sonya L Heltshe; Assem Ziady; Tom Kelley; Frank Accurso; Joseph Pilewski; Nicole Mayer-Hamblett; Elizabeth Joseloff; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2016-10-27       Impact factor: 5.482

Review 7.  Features and regulation of non-enzymatic post-translational modifications.

Authors:  Robert Harmel; Dorothea Fiedler
Journal:  Nat Chem Biol       Date:  2018-02-14       Impact factor: 15.040

8.  Chemistry and biology of reactive oxygen species in signaling or stress responses.

Authors:  Bryan C Dickinson; Christopher J Chang
Journal:  Nat Chem Biol       Date:  2011-07-18       Impact factor: 15.040

9.  Determination of thiocyanate in exhaled breath condensate.

Authors:  Joshua D Chandler; Hamed Horati; Douglas I Walker; Enea Pagliano; Rabindra Tirouvanziam; Mieke Veltman; Bob J Scholte; Hettie M Janssens; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2018-08-22       Impact factor: 7.376

10.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.